Mersana Therapeutics, Inc. Net Income
Mersana Therapeutics, Inc. reported Net Income of -$7.54 million for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLoss · last filed 2025-11-14
- Mersana Therapeutics, Inc. net income (loss) attributable to parent for the quarter ending 2025-09-30 was -$7.54M.
- Mersana Therapeutics, Inc. net income (loss) attributable to parent for the quarter ending 2025-06-30 was -$24.30M.
- Mersana Therapeutics, Inc. net income (loss) attributable to parent for the quarter ending 2025-03-31 was -$24.12M.
- Mersana Therapeutics, Inc. net income (loss) attributable to parent for the quarter ending 2024-12-31 was -$14.12M.
- Mersana Therapeutics, Inc. net income (loss) attributable to parent for fiscal 2024 was -$69.19M.
- Mersana Therapeutics, Inc. net income (loss) attributable to parent for fiscal 2023 was -$171.67M.
- Mersana Therapeutics, Inc. net income (loss) attributable to parent for fiscal 2022 was -$204.21M.
- Mersana Therapeutics, Inc. net income (loss) attributable to parent for fiscal 2021 was -$170.06M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 12 month |
|---|---|---|---|---|
| 2025-09-30 | -$7.54M 10-Q · filed 2025-11-14 | -$31.84M derived: sum of 2 quarters · filed 2025-11-14 | -$55.96M 10-Q · filed 2025-11-14 | -$70.08M derived: sum of 4 quarters · filed 2025-11-14 |
| 2025-06-30 | -$24.30M 10-Q · filed 2025-11-14 | -$48.42M 10-Q · filed 2025-08-13 | -$62.54M derived: sum of 3 quarters · filed 2025-11-14 | -$74.04M derived: sum of 4 quarters · filed 2025-11-14 |
| 2025-03-31 | -$24.12M 10-Q · filed 2025-11-14 | -$38.24M derived: sum of 2 quarters · filed 2025-11-14 | -$49.74M derived: sum of 3 quarters · filed 2025-11-14 | -$74.01M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-12-31 | -$14.12M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$25.62M derived: sum of 2 quarters · filed 2025-11-14 | -$49.89M derived: sum of 3 quarters · filed 2025-11-14 | -$69.19M 10-K · filed 2025-03-03 |
| 2024-09-30 | -$11.50M 10-Q · filed 2025-11-14 | -$35.77M derived: sum of 2 quarters · filed 2025-11-14 | -$55.08M 10-Q · filed 2025-11-14 | -$74.62M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | -$24.27M 10-Q · filed 2025-11-14 | -$43.57M 10-Q · filed 2025-08-13 | -$63.12M derived: sum of 3 quarters · filed 2025-11-14 | -$104.77M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-03-31 | -$19.31M 10-Q · filed 2025-11-14 | -$38.85M derived: sum of 2 quarters · filed 2025-11-14 | -$80.51M derived: sum of 3 quarters · filed 2025-11-14 | -$134.81M derived: sum of 4 quarters · filed 2025-11-14 |
| 2023-12-31 | -$19.54M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$61.20M derived: sum of 2 quarters · filed 2025-03-03 | -$115.51M derived: sum of 3 quarters · filed 2025-03-03 | -$171.67M 10-K · filed 2025-03-03 |
| 2023-09-30 | -$41.66M 10-Q · filed 2024-11-13 | -$95.96M derived: sum of 2 quarters · filed 2024-11-13 | -$152.13M 10-Q · filed 2024-11-13 | -$197.05M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | -$54.31M 10-Q · filed 2024-11-13 | -$110.47M 10-Q · filed 2024-08-13 | -$155.39M derived: sum of 3 quarters · filed 2025-03-03 | -$215.21M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | -$56.16M 10-Q · filed 2024-11-13 | -$101.09M derived: sum of 2 quarters · filed 2025-03-03 | -$160.90M derived: sum of 3 quarters · filed 2025-03-03 | -$213.12M derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | -$44.92M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$104.73M derived: sum of 2 quarters · filed 2025-03-03 | -$156.95M derived: sum of 3 quarters · filed 2025-03-03 | -$204.21M 10-K · filed 2025-03-03 |
| 2022-09-30 | -$59.81M 10-Q · filed 2023-11-07 | -$112.03M derived: sum of 2 quarters · filed 2023-11-07 | -$159.29M 10-Q · filed 2023-11-07 | -$208.27M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | -$52.22M 10-Q · filed 2023-11-07 | -$99.48M 10-Q · filed 2023-08-08 | -$148.46M derived: sum of 3 quarters · filed 2024-02-28 | -$193.93M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | -$47.26M 10-Q · filed 2023-11-07 | -$96.24M derived: sum of 2 quarters · filed 2024-02-28 | -$141.71M derived: sum of 3 quarters · filed 2024-02-28 | -$182.63M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | -$48.98M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$94.45M derived: sum of 2 quarters · filed 2024-02-28 | -$135.37M derived: sum of 3 quarters · filed 2024-02-28 | -$170.06M 10-K · filed 2024-02-28 |
| 2021-09-30 | -$45.47M 10-Q · filed 2022-11-07 | -$86.38M derived: sum of 2 quarters · filed 2022-11-07 | -$121.08M 10-Q · filed 2022-11-07 | -$149.92M derived: sum of 4 quarters · filed 2022-11-07 |
| 2021-06-30 | -$40.91M 10-Q · filed 2022-11-07 | -$75.61M 10-Q · filed 2022-08-08 | -$104.45M derived: sum of 3 quarters · filed 2022-11-07 | -$126.94M derived: sum of 4 quarters · filed 2022-11-07 |
| 2021-03-31 | -$34.69M 10-Q · filed 2022-11-07 | -$63.54M derived: sum of 2 quarters · filed 2022-11-07 | -$86.03M derived: sum of 3 quarters · filed 2022-11-07 | -$105.81M derived: sum of 4 quarters · filed 2022-11-07 |
| 2020-12-31 | -$28.84M 10-Q · filed 2021-11-09 | -$51.33M derived: sum of 2 quarters · filed 2021-11-09 | -$71.12M derived: sum of 3 quarters · filed 2021-11-09 | -$88.05M 10-K · filed 2023-02-28 |
| 2020-09-30 | -$22.49M 10-Q · filed 2021-11-09 | -$42.27M derived: sum of 2 quarters · filed 2021-11-09 | -$59.20M 10-Q · filed 2021-11-09 | -$75.45M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | -$19.79M 10-Q · filed 2021-11-09 | -$36.71M 10-Q · filed 2021-08-06 | -$52.96M derived: sum of 3 quarters · filed 2021-11-09 | -$69.75M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-03-31 | -$16.93M 10-Q · filed 2021-11-09 | -$33.17M derived: sum of 2 quarters · filed 2021-11-09 | -$49.96M derived: sum of 3 quarters · filed 2021-11-09 | -$67.03M derived: sum of 4 quarters · filed 2021-11-09 |
| 2019-12-31 | -$16.25M 10-K · filed 2021-02-26 | -$33.04M derived: sum of 2 quarters · filed 2021-02-26 | -$50.11M derived: sum of 3 quarters · filed 2021-02-26 | -$28.21M 10-K · filed 2022-02-28 |
| 2019-09-30 | -$16.79M 10-K · filed 2021-02-26 | -$33.86M derived: sum of 2 quarters · filed 2021-02-26 | -$11.96M 10-Q · filed 2020-11-09 | -$34.39M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | -$17.07M 10-K · filed 2021-02-26 | $4.83M 10-Q · filed 2020-08-07 | -$17.60M derived: sum of 3 quarters · filed 2021-02-26 | -$34.67M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | $21.90M 10-K · filed 2021-02-26 | -$530.00K derived: sum of 2 quarters · filed 2021-02-26 | -$17.60M derived: sum of 3 quarters · filed 2021-02-26 | -$29.95M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | -$22.43M 10-K · filed 2020-02-28 | -$39.50M derived: sum of 2 quarters · filed 2020-02-28 | -$51.85M derived: sum of 3 quarters · filed 2020-02-28 | -$64.26M 10-K · filed 2021-02-26 |
| 2018-09-30 | -$17.07M 10-K · filed 2020-02-28 | -$29.42M derived: sum of 2 quarters · filed 2020-02-28 | -$41.83M 10-Q · filed 2019-11-06 | -$55.79M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-06-30 | -$12.35M 10-K · filed 2020-02-28 | -$24.76M 10-Q · filed 2019-08-08 | -$38.73M derived: sum of 3 quarters · filed 2020-02-28 | -$46.46M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-03-31 | -$12.40M 10-K · filed 2020-02-28 | -$26.37M derived: sum of 2 quarters · filed 2020-02-28 | -$34.10M derived: sum of 3 quarters · filed 2020-02-28 | -$43.05M derived: sum of 4 quarters · filed 2020-02-28 |
| 2017-12-31 | -$13.97M 10-K · filed 2019-03-08 | -$21.70M derived: sum of 2 quarters · filed 2019-03-08 | -$30.65M derived: sum of 3 quarters · filed 2019-03-08 | -$38.71M 10-K · filed 2020-02-28 |
| 2017-09-30 | -$7.73M 10-K · filed 2019-03-08 | -$16.68M derived: sum of 2 quarters · filed 2019-03-08 | -$24.74M 10-Q · filed 2017-11-13 | -$23.48M derived: sum of 4 quarters · filed 2019-03-08 |
| 2017-06-30 | -$8.95M 10-K · filed 2019-03-08 | -$17.01M 10-Q · filed 2017-08-11 | -$15.75M derived: sum of 3 quarters · filed 2019-03-08 | -$21.59M derived: sum of 4 quarters · filed 2019-03-08 |
| 2017-03-31 | -$8.06M 10-K · filed 2019-03-08 | -$6.80M derived: sum of 2 quarters · filed 2019-03-08 | -$12.64M derived: sum of 3 quarters · filed 2019-03-08 | -$16.41M derived: sum of 4 quarters · filed 2019-03-08 |
| 2016-12-31 | $1.26M 10-K · filed 2018-03-28 | -$4.58M derived: sum of 2 quarters · filed 2018-03-28 | -$8.34M derived: sum of 3 quarters · filed 2018-03-28 | -$13.70M 10-K · filed 2019-03-08 |
| 2016-09-30 | -$5.84M 10-K · filed 2018-03-28 | -$9.60M derived: sum of 2 quarters · filed 2018-03-28 | -$14.96M 10-Q · filed 2017-11-13 | |
| 2016-06-30 | -$3.77M 10-K · filed 2018-03-28 | -$9.12M 10-Q · filed 2017-08-11 | ||
| 2016-03-31 | -$5.36M 10-K · filed 2018-03-28 | |||
| 2015-12-31 | -$16.43M 10-K · filed 2018-03-28 |